Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Regeneron Blockade Leaves Biocon Facing 2027 Wait On US Eylea Biosimilar
Four Other Firms Also Facing Up To Injunctive Relief Ahead Of Infringement Trial
Jun 12 2024
•
By
Dean Rudge
• Source: Shutterstock
(Andriy Popov / Alamy Stock Photo/Alamy Stock Photo)
More from Legal & IP
More from Generics Bulletin
